$465.39 Million in Sales Expected for Gentex Co. (GNTX) This Quarter

Wall Street brokerages expect Gentex Co. (NASDAQ:GNTX) to report sales of $465.39 million for the current quarter, Zacks reports. Six analysts have provided estimates for Gentex’s earnings. The lowest sales estimate is $454.60 million and the highest is $473.90 million. Gentex posted sales of $465.42 million during the same quarter last year, which would indicate a negative year over year growth rate of 0%. The business is scheduled to issue its next earnings report on Friday, April 19th.

On average, analysts expect that Gentex will report full year sales of $1.88 billion for the current fiscal year, with estimates ranging from $1.85 billion to $1.89 billion. For the next financial year, analysts anticipate that the business will report sales of $1.98 billion, with estimates ranging from $1.92 billion to $2.02 billion. Zacks’ sales calculations are an average based on a survey of sell-side analysts that cover Gentex.

Gentex (NASDAQ:GNTX) last issued its earnings results on Wednesday, January 30th. The auto parts company reported $0.41 EPS for the quarter, missing the Thomson Reuters’ consensus estimate of $0.43 by ($0.02). The business had revenue of $453.40 million for the quarter, compared to analyst estimates of $477.41 million. Gentex had a return on equity of 23.06% and a net margin of 23.88%. The firm’s revenue was down 1.3% compared to the same quarter last year. During the same period in the previous year, the firm posted $0.46 EPS.

Several research analysts have commented on the company. BMO Capital Markets lowered their target price on Gentex from $25.00 to $24.00 and set a “buy” rating for the company in a research note on Monday, October 22nd. ValuEngine raised Gentex from a “sell” rating to a “hold” rating in a research note on Monday, October 22nd. Robert W. Baird boosted their target price on Gentex from $19.00 to $20.00 and gave the stock a “neutral” rating in a research note on Monday, October 22nd. Craig Hallum reissued a “hold” rating and set a $20.00 target price on shares of Gentex in a research note on Friday, October 19th. Finally, Longbow Research downgraded Gentex from a “buy” rating to a “neutral” rating and set a $20.65 target price for the company. in a research note on Tuesday, February 5th. One research analyst has rated the stock with a sell rating, nine have issued a hold rating and two have given a buy rating to the stock. The company currently has a consensus rating of “Hold” and an average target price of $22.46.

Shares of NASDAQ GNTX opened at $19.88 on Thursday. The stock has a market cap of $5.28 billion, a price-to-earnings ratio of 12.27, a price-to-earnings-growth ratio of 1.44 and a beta of 1.09. Gentex has a 12 month low of $17.80 and a 12 month high of $25.41.

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, January 23rd. Stockholders of record on Wednesday, January 9th were paid a $0.11 dividend. This represents a $0.44 annualized dividend and a dividend yield of 2.21%. The ex-dividend date was Tuesday, January 8th. Gentex’s dividend payout ratio is currently 27.16%.

In other news, General Counsel Scott P. Ryan sold 3,000 shares of the company’s stock in a transaction that occurred on Sunday, December 30th. The stock was sold at an average price of $19.88, for a total value of $59,640.00. Following the completion of the transaction, the general counsel now owns 22,513 shares of the company’s stock, valued at $447,558.44. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, Director James H. Wallace sold 24,000 shares of the company’s stock in a transaction that occurred on Thursday, January 31st. The shares were sold at an average price of $21.40, for a total value of $513,600.00. Following the completion of the transaction, the director now directly owns 29,400 shares of the company’s stock, valued at approximately $629,160. The disclosure for this sale can be found here. Insiders sold 30,000 shares of company stock valued at $632,880 in the last ninety days. 0.60% of the stock is currently owned by insiders.

A number of large investors have recently added to or reduced their stakes in the business. Bremer Trust National Association bought a new position in shares of Gentex during the 4th quarter worth approximately $25,000. Patriot Financial Group Insurance Agency LLC bought a new position in shares of Gentex during the 4th quarter worth approximately $27,000. Lindbrook Capital LLC bought a new position in shares of Gentex during the 4th quarter worth approximately $32,000. Enlightenment Research LLC bought a new position in shares of Gentex during the 4th quarter worth approximately $36,000. Finally, Parallel Advisors LLC boosted its holdings in shares of Gentex by 728.0% during the 4th quarter. Parallel Advisors LLC now owns 2,310 shares of the auto parts company’s stock worth $46,000 after buying an additional 2,031 shares in the last quarter. 85.90% of the stock is owned by institutional investors and hedge funds.

About Gentex

Gentex Corporation provides automatic-dimming and non-dimming rearview mirrors, and electronics for the automotive industry; dimmable aircraft windows for the aviation industry; and commercial smoke alarms and signaling devices for the fire protection industry worldwide. It designs, develops, manufactures, and markets automotive products, including interior and exterior electrochromic automatic-dimming rearview mirrors, automotive electronics, and interior and exterior non-automatic-dimming rearview mirrors with electronic features for automotive passenger cars, light trucks, pick-up trucks, sport utility vehicles, and vans for original equipment manufacturers, tier one automotive mirror manufacturers, and various aftermarket and accessory customers.

Further Reading: Return on Investment (ROI)

Get a free copy of the Zacks research report on Gentex (GNTX)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Gentex (NASDAQ:GNTX)

Receive News & Ratings for Gentex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Gentex and related companies with MarketBeat.com's FREE daily email newsletter.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on reddit